Eylea and Arthritis - a phase IV clinical study of FDA data

Summary:

Arthritis is reported as a side effect among people who take Eylea (aflibercept), especially for people who are female, 60+ old, also take Synthroid, and have Age-related macular degeneration.

The phase IV clinical study analyzes which people have Arthritis when taking Eylea. It is created by eHealthMe based on reports of 27,819 people who have side effects when taking Eylea from the FDA, and is updated regularly.

What is Eylea?

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. eHealthMe is studying from 27,868 Eylea users. Check the latest studies of Eylea.

What is Arthritis?

Arthritis (form of joint disorder that involves inflammation of one or more joints) is found to be associated with 1,961 drugs and 2,259 conditions by eHealthMe. Check the latest studies of Arthritis.

On Jul, 12, 2026

27,819 people reported to have side effects when taking Eylea.
Among them, 25 people (0.09%) have Arthritis.

Among these 25 people:

What is the gender of people who have Arthritis when taking Eylea? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Arthritis when taking Eylea? *

What are other drugs people take besides Eylea? *

What are other side effects people have besides Arthritis? *

Visual Impairment: 5 people, 20.00%
Pain: 4 people, 16.00%
Fall: 4 people, 16.00%
Hypersensitivity: 4 people, 16.00%
Vision Blurred: 4 people, 16.00%
Joint Pain: 3 people, 12.00%
Eye Discharge: 3 people, 12.00%
Drug Hypersensitivity: 3 people, 12.00%
Blindness Transient (sudden loss of vision): 3 people, 12.00%
Pain In Extremity: 3 people, 12.00%

What are the existing conditions these people have? *

Eye Disorder: 2 people, 8.00%
Age-Related Macular Degeneration: 2 people, 8.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.00%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 1 person, 4.00%
Primary Immunodeficiency Syndrome: 1 person, 4.00%
Optic Ischaemic Neuropathy (optic nerve damage due to lack of blood supply): 1 person, 4.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 4.00%
Lacrimation Increased: 1 person, 4.00%
Indigestion: 1 person, 4.00%
Immunodeficiency Common Variable: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Eylea and have Arthritis?

- Check whether Arthritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eylea:

Eylea (27,868 reports)

Arthritis treatments and more:

Arthritis (188,667 reports)

Browse all side effects of Eylea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arthritis:

Arthritis (1,961 drugs)

Browse all the conditions that are associated with Arthritis:

Arthritis (2,259 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aflibercept (the active ingredients of Eylea) and Eylea (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.